Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphangiomyomas”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Testing effectiveness (Phase 2)Study completedNCT00005906
What this trial is testing

Treatment With Octreotide in Patients With Lymphangioleiomyomatosis

Who this might be right for
LymphangioleiomyomatosisLymphangiomyomasPleural Effusions+1 more
National Heart, Lung, and Blood Institute (NHLBI) 4
Early research (Phase 1)Looking for participantsNCT06889168
What this trial is testing

Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Lymphangioleiomyomatosis (LAM)Lymphangioleiomyomatosis
Columbia University 20
Early research (Phase 1)Study completedNCT04388371
What this trial is testing

Glutamine PET Imaging in LAM

Who this might be right for
Lymphangioleiomyomatosis (LAM)
Vanderbilt University Medical Center 5
Not applicableLooking for participantsNCT06405997
What this trial is testing

The Genotype and Phenotype of Lymphangioleiomyomatosis

Who this might be right for
Sporadic LymphangioleiomyomatosisTSC-associated Lymphangioleiomyomatosis
National Taiwan University Hospital 100
Not applicableUnknownNCT05617105
What this trial is testing

Molecular Characterization of Perivascular Epithelioid Cell Tumors

Who this might be right for
Perivascular Epithelioid Cell Tumor, Malignant
University Hospital, Strasbourg, France 100
Post-approval studies (Phase 4)Study completedNCT00989742
What this trial is testing

Doxycycline In Lymphangioleiomyomatosis (LAM)

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis
University of Nottingham 24
Not applicableStudy completedNCT00366509
What this trial is testing

Role of Helicobacter Pylori and Its Toxins in Lung and Digestive System Diseases

Who this might be right for
Pulmonary DiseaseOropharyngeal DiseaseLymphangioleiomyomatosis+3 more
National Heart, Lung, and Blood Institute (NHLBI) 157
Testing effectiveness (Phase 2)Study completedNCT03131999
What this trial is testing

LAM Pilot Study With Imatinib Mesylate

Who this might be right for
Lymphangioleiomyomatosis
Medical University of South Carolina 18
Not applicableStudy completedNCT00001869
What this trial is testing

Official Record of Patients Diagnosed With Lymphangioleiomyomatosis (LAM)

Who this might be right for
Leiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI) 400
Not applicableStudy completedNCT02859194
What this trial is testing

The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients

Who this might be right for
Interstitial Pulmonary Fibrosis ARDSCOPD (Chronic Obstructive Pulmonary Disease)Bronchiectasis+3 more
Yonsei University 10
Not applicableLooking for participantsNCT05676099
What this trial is testing

TSC Biosample Repository and Natural History Database

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
National Tuberous Sclerosis Association 5,000
Very early researchUnknownNCT05087134
What this trial is testing

Characterizing LAM With 11C-Choline PET/CT

Who this might be right for
Lymphangioleiomyomatosis
Peking Union Medical College Hospital 50
Not applicableStudy completedNCT05323370
What this trial is testing

Lymphangioleiomyomatosis, a Study on Cathepsin K

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University Hospital, Tours 19
Not applicableLooking for participantsNCT07304856
What this trial is testing

Role of Extracellular Vesicles as Biomarkers of Pulmonary Involvement in Patients With Lymphangioleiomyomatosis and Tuberous Sclerosis Complex

Who this might be right for
Lymphangioleiomyomatosis (LAM)Extracellular Vesicles; Generation and Function
University of Milan 80
Not applicableStudy completedNCT04184193
What this trial is testing

Benefits of Pulmonary Rehabilitation in Patients With Severe Lymphangioleiomyomatosis (LAM)

Who this might be right for
LymphangioleiomyomatosisLAMPulmonary Rehabilitation
Schön Klinik Berchtesgadener Land 58
Testing effectiveness (Phase 2)Study completedNCT01059318
What this trial is testing

Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
Novartis Pharmaceuticals 24
Early research (Phase 1)Active Not RecruitingNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 155
Not applicableStudy completedNCT02009241
What this trial is testing

Pulmonary Rehabilitation in Lymphangioleiomyomatosis

Who this might be right for
Lymphangioleiomyomatosis
University of Sao Paulo General Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02061397
What this trial is testing

Safety of Simvastatin in LAM and TSC

Who this might be right for
LymphangioleiomyomatosisTuberous Sclerosis Complex
University of Pennsylvania 10
Not applicableStudy completedNCT00005486
What this trial is testing

Lymphangioleiomyomatosis (LAM) Registry

Who this might be right for
Lung DiseasesLymphangiomyomatosis
National Heart, Lung, and Blood Institute (NHLBI)
Load More Results